SIRT6 and metabolic dysfunction-associated steatotic liver disease: Our results indicate a reduction in Sirt6 expression in NAFLD and other conditions associated with ER stress, and the consequent increase in XBP1s activity via acetylation-dependent protein stabilization leads to enhanced steatosis, insulin resistance, and injury in the liver.